Lv41
418 积分 2022-09-26 加入
New therapies for systemic lupus erythematosus — past imperfect, future tense
18天前
已完结
2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
1个月前
已关闭
Clinical efficacy of belimumab in patients with systemic lupus erythematosus and headache. A report of two cases
1个月前
已完结
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
1个月前
已完结
Eltrombopag in severe immune thrombocytopenia secondary to connective tissue disease: a report of 17 patients and literature review
1个月前
已完结
Plasma Exchange and Rituximab in the Management of Acute Occlusive Retinal Vasculopathy Secondary to Systemic Lupus Erythematosus
1个月前
已完结
Rituximab for Sight-Threatening Lupus-Related Retinal Vasculitis
1个月前
已完结
Efficacy and safety of an anti‐CD20 monoclonal antibody, rituximab, for lupus nephritis: A meta‐analysis
1个月前
已完结
Rituximab therapy for adult refractory systemic lupus erythematosus with neurological and/or psychiatric presentations: a PRISMA-compliant meta-analysis
1个月前
已完结
Efficacy and safety of rituximab in patients with lupus nephritis: A systematic review and meta-analysis
1个月前
已完结
皖公网安备34019202002308
